This lesson aims to provide details of the acute safety, efficacy and advantages of PVI using POLARx cryoablation for paroxysmal AF, and compares the procedural efficacy and biophysical parameters to AFA-Pro.

The learning outcomes tab provides details of the required level of understanding.

This lesson provides learning on the following topics:

• Introduction by Prof Morgan
• Acute safety, efficacy and advantages of novel cryoablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience by Dr Anic
• Comparison of procedural efficacy and biophysical parameters between two competing cryoballoon technologies for pulmonary vein isolation: insights from an initial multicentre experience by Dr Yap
• Discussion & conclusions

On completion of this lesson you should be able to:

1. Outline the safety, efficacy and advantages of POLARx cryoablation for PVI in paroxysmal AF
2. Compare procedural efficacy and biophysical parameters of POLARx with AFA-Pro for PVI
3. Highlight temperature monitoring during POLARx cryoablation
4. Consider tip-length in case preparation
5. Discuss DMS in phrenic nerve monitoring
6. Highlight the POLARx catheter handling characteristics compared to AFA-Pro

There is no assessment associated with this lesson.